The present invention relates to intermediates to 6-substituted purine carbocyclic nucleosides, which are useful in medical therapy particularly in the treatment of HIV and HBV infections.
本发明涉及 6-取代嘌呤碳环核苷的中间体,这些中间体可用于医疗,特别是治疗 HIV 和 HBV 感染。
Therapeutic nucleosides
申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0434450B1
公开(公告)日:1999-07-07
CRYSTALLINE ABACAVIR HYDROCHLORIDE MONOHYDRATE AND PROCESS FOR ITS PREPARATION
申请人:Lupin Limited
公开号:EP3052499A1
公开(公告)日:2016-08-10
US5206435A
申请人:——
公开号:US5206435A
公开(公告)日:1993-04-27
[EN] CRYSTALLINE ABACAVIR HYDROCHLORIDE MONOHYDRATE AND PROCESS FOR ITS PREPARATION<br/>[FR] MONOHYDRATE DE CHLORHYDRATE D'ABACAVIR DE FORME CRISTALLINE ET PROCÉDÉ POUR SA PRÉPARATION
申请人:LUPIN LTD
公开号:WO2015049623A1
公开(公告)日:2015-04-09
The present invention relates to crystalline abacavir hydrochloride monohydrate. The present invention further provides a process for preparation of crystalline abacavir hydrochloride monohydrate by dissolving abacavir hydrochloride in aqueous C1 -C4 alcoholic solvent, cooling the solution, and isolating the crystalline solid.